Podcasts about semmelweis university

As part of IASLC's ongoing series of podcasts in world languages, Dr. Balazs Halmos moderates a discussion in Hungarian with Dr. Krisztina Bogos, Dr. Ferenc Rényi-Vámos and Dr. Zsolt Megyesfalvi. The podcast reviews recent advances in lung cancer screening, diagnosis and management with a particular focus on implementation in Hungary. Highlights of the discussion include novel staging and diagnostic tools, state-of-the-art biomarker testing, perioperative therapy and clinical trials access. Host: Balazs Halmos, MD, Director, Thoracic Oncology & Clinical Cancer Genomics, Montefiore Medical Park at Eastchester, Bronx, New York Guest: Ferenc Rényi-Vámos, MD, PhD, Thoracic Surgery, Semmelweis University and National Institute of Oncology, Budapest, Hungary Guest: Krisztina Bogos, MD, Thoracic Oncology National Koranyi Institute of Pulmonology, Budapest, Hungary Lung Cancer Research and Pathology Guest: Zsolt Megyesfalvi, MD, PhD, Semmelweis University and National Institute of Oncology, Budapest, Hungary and National Koranyi Institute of Pulmonology, Budapest, Hungary

Audible Bleeding editor Wen (@WenKawaji) is joined by 3rd year medical student Nishi (@Nishi_Vootukuru), JVS editor Dr. Forbes (@TL_Forbes), and JVS-CIT associate editor Dr. Jimenez to discuss some of our favorite articles in the JVS family of journals. This episode hosts Dr. Trisha Roy (@trisharoymd), Dr. Judit Csore (@JuditCsore), and Dr. Maham Rahimi, the authors of the following papers.    Articles: Employing magnetic resonance histology for precision chronic limb-threatening ischemia treatment plan Biodesign: Engineering an aortic endograft explantation tool    Show Guests  Dr. Trisha Roy- Assistant professor of cardiovascular surgery at the Houston Methodist Debakey Heart and Vascular Center. Background of Material engineering, vascular imaging, research interest in peripheral vascular disease. Dr. Judit Csore-Radiologist and assistant lecturer at the Heart and Vascular Center of Semmelweis University, Budapest, Hungary. Her primary focus is on cardiovascular imaging and vascular MRI. She recently spent two years in the United States at Houston Methodist Hospital, where she had been collaborating with Dr. Trisha Roy since 2022 as a postdoctoral fellow, specializing in peripheral arterial disease imaging. Dr. Maham Rahimi-Associate professor in the department of cardiovascular surgery at Houston Methodist Hospital, His research interests include nanotechnology and Biomedical Engineering Follow us @audiblebleeding Learn more about us at  https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

Audible Bleeding editor Wen (@WenKawaji) is joined by 3rd year medical student Nishi (@Nishi_Vootukuru), JVS editor Dr. Forbes (@TL_Forbes), and JVS-CIT associate editor Dr. Jimenez to discuss some of our favorite articles in the JVS family of journals. This episode hosts Dr. Trisha Roy, Dr. Judit Csore, and Dr. Maham Rahimi, the authors of the following papers.    Articles:   Employing magnetic resonance histology for precision chronic limb-threatening ischemia treatment plan Biodesign: Engineering an aortic endograft explantation tool    Show Guests  Dr. Trisha Roy- Assistant professor of cardiovascular surgery at the Houston Methodist Debakey Heart and Vascular Center. Background of Material engineering, vascular imaging, research interest in peripheral vascular disease. Dr. Judit Csore-Radiologist and assistant lecturer at the Heart and Vascular Center of Semmelweis University, Budapest, Hungary. Her primary focus is on cardiovascular imaging and vascular MRI. She recently spent two years in the United States at Houston Methodist Hospital, where she had been collaborating with Dr. Trisha Roy since 2022 as a postdoctoral fellow, specializing in peripheral arterial disease imaging. Dr. Maham Rahimi-Associate professor in the department of cardiovascular surgery at Houston Methodist Hospital, His research interests include nanotechnology and Biomedical Engineering Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

Ilona Csula Moric was born in 1958 and is a proud mother of two beautiful children. She graduated from Semmelweis University of Szeged's Faculty of Pharmacy in Hungary. She moved to Canada in 1991 to begin her new life. Ilona lives in North Vancouver, British Columbia.  She has not only embraced the joy of motherhood but has also conquered personal medical challenges that shaped her into the inspirational figure she is today.   Ilona's journey unfolds within the pages of her impactful book, The 10% Chance, where she vulnerably shares her triumphant personal odyssey. This memoir is a testament to her unwavering determination to surmount formidable obstacles, offering readers a glimpse into the power of resilience and the human spirit.      https://ilonacsula.com Facebook: @ilona.csulamoric Instagram: @ilona_moric LinkedIn: @ilona-csula-moric   About The Flare Up Show Find Chrissy Cordingley at ⁠⁠⁠⁠https://www.risethrive.ca⁠⁠⁠⁠ Follow the Flare Up Show on ⁠⁠⁠⁠Instagram⁠⁠⁠⁠ Join the Rise and Thrive Wholeness Community on ⁠⁠⁠⁠Facebook⁠⁠⁠ Welcome to The Flare Up Show with Chrissy Cordingley. We tackle tough health topics with humor, share epic comeback stories, and explore ways to boost your mind and body. Whether you're feeling meh or need a laugh, join us for expert tips, inspiring chats, and a dash of fun to help you flare up to your best self. Ready to rise and thrive? Tune in and let's set your journey on fire! #TheFlareUpShow #RiseAndThrivePodcast #WholenessCoaching #WholeBeing #WellBeing #ReAlign #ReAlive #ElevateYourLife VIDEO MUSIC Credit; Happy Place Courtesy of ClipChamp Audio version Music Credit: Y2K by Lunareh

Dr Zsofia Drobni is a Cardiology Fellow at Semmelweis University, Budapest, HU. Her research focuses on the utility of cardiac CT and MRI in patients receiving cardiotoxic therapies, with a specific focus on immune checkpoint inhibitors. Dr Drobni graduated in 2017 from Semmelweis University, in Hungary, and continued her PhD studies at Semmelweis. Her PhD thesis was on “new perspectives of CT-based cardiovascular risk assessment”. From 2019, Dr Drobni was a research fellow at the Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard University. Dr Drobni is currently the president of and founded the Hungarian Chapter of IC-OS.

One way to future-proof students in our globalised world is to improve their cross-cultural communication skills. With students and academics more mobile than ever, the ability to reach across divides – be they language, culture, religion, economic or location – will be in demand whatever the workplace. These skills offer a path to belonging, innovating, being effective and thriving in higher education and industry. For this episode, we talk to two very different experts in cross-cultural education; one works in medical and healthcare communication in Hungary and the other teaches creative writing and other media in the mountains of Central Asia. They share their advice for creating a classroom that supports language learning and understanding, how teaching can adapt to maximise the benefits of an international student cohort, connecting practical clinical skills with functional language, and how language learning itself creates more empathetic communication. Lucy Palmer is a senior lecturer of communications and media based at the Naryn campus of the University of Central Asia in Kyrgyzstan. She is also a former foreign correspondent and a successful memoir writer. Katalin Fogarasi is an associate professor and director of the Institute of Languages for Specific Purposes at Semmelweis University in Budapest, Hungary.

Have you tried everything, but you're still depressed? Don't miss this episode if this is you or someone you know. I am excited to chat with Dr.Heeramun. Dr. Vineka Heeramun is a dual board-certified Psychiatrist and internist who practices as an inpatient and outpatient in Utah. She attended Medical school at Semmelweis University and completed a residency at SIU-Southern Illinois University. She is also the founder and CEO of Joyful Horizon Psychiatry, where she specializes in cutting-edge treatments like Transcranial Magnetic Stimulation (TMS) for treatment-resistant depression, OCD, and anxiety and spravato (intranasal ketamine) for refractory depression and acute suicidality. Her goal is to help patients feel joy and regain their lives by mastering their mental health. IG/TikTok:joyfulhorizonjoyfulhorizon --- Send in a voice message: https://podcasters.spotify.com/pod/show/urcaringdocs/message

With Filippo Cademartiri, Fondazione Monasterio, Pisa - Italy & Pàl Maurovich-Horvat, Semmelweis University, Budapest - Hungary. Link to paper Link to editorial

Interview with Dr Eva Kereszty, doctor, teacher and forensic medical expert, among others. We talk about her vision for the future of cities, urban services, holistic thinking, expanded disability meaning, and many more. Dr Eva Kereszty graduated from Semmelweis University with forensic medicine and insurance medicine and from Eötvös Loránd University of Budapest with administrative law specialisations. She spent time in the US and various European countries in short-term fellowships. Eva teaches forensic medicine and insurance medicine, health law, patients' rights, and public administration to graduate and post-graduate students in the Hungarian and English language programs at the medical and law faculties. She was the head of the 2-year post-graduate licence program for medical professionals in law, and she was awarded the „Best Teacher of the Course” award by the students several times. Eva participated in the preparations for the European Union accession of Hungary in the Hungarian ministry. She represented Hungary in the High-Level Committee for Health and the Governmental Committee of the European Social Charter. Eva also supervised and participated in the legislation of legal tools in health., e.g. the Health Act of Hungary. You can find out more about Éva through these links: Dr Éva Kereszty on LinkedIn; Dr Éva Kereszty at the Hungarian Academy of Sciences; Dr Éva Kereszty on ORCID; Dr Éva Kereszty on Google Scholar; Dr Éva Kereszty at the Hungarian Doctoral Council; Halottak, akik köztünk élnek - book by Dr Éva Kereszty (HUN) - Dead who live among us (rough translation for the title); What wast the most interesting part for you? What questions did arise for you? Let me know on twitter @WTF4Cities! I hope this was an interesting episode for you and thanks for tuning in. Music by Lesfm from Pixabay

Dr. Zsuzsanna Devecseri is the Vice President and Head of Global Oncology Medical Affairs at Sanofi. She leads a team of experts responsible for regulatory submission strategy, scientific communication, and innovative approaches to curing prostate and genitourinary cancer. Dr. Devecseri has held several prominent positions within the organization including Senior Director, Global Medical Lead of Pompe Disease and Director of Medical Affairs, Strategic Planning and Operations. Prior to joining Sanofi, she served as the Director of Client Services for ABN AMRO Life and Pension Insurance Company. Dr. Devecseri earned her medical degree from Semmelweis University and her MBA from Corvinus University of Budapest. She has also gone on to earn 4 certifications, including a Certificate in Health Economics and Outcomes Research from the University of Washington. Learn more about Dr. Devecseri at https://atchainternational.com/healthcare-and-higher-podcast-ep33-zsuzsanna-devecseri/ Are you a healthcare professional or healthcare executive looking to advance your career, build a better brand, or create a leadership legacy? Iqbal can help! Schedule your FREE CONSULTATION today at https://atchainternational.com Connect with Iqbal on: - Linked at https://www.linkedin.com/in/iqbalatcha/ - Instagram at https://www.instagram.com/iqbalatcha1 - Twitter at https://twitter.com/IqbalAtcha1 Join us next week for another exciting episode of the "Healthcare and Higher" podcast! #HealthcareAndHigher #IqbalsInterviews Song Credits: "Life Is A Dream" by Michael Ramir C. "Stay With Me" by Michael Ramir C. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/iqbal-atcha/support

Pomegranate peel has protective effects against enteropathogenic bacteria US Department of Agriculture, August 31, 2021 A recent study by the U.S. Department of Agriculture revealed that pomegranate peel extract contains bioactive compounds that have potential antibacterial activity. The study's findings were published in the journal Nutrition Research. Pomegranate fruit peel is considered an agricultural waste product. However, it is a rich source of polyphenols like punicalins, punicalagins and ellagic acids. Earlier studies have shown that products derived from pomegranates have health benefits, including antibacterial activity, in vitro. There is limited evidence, however, of their antibacterial activity in vivo. For this study, researchers sought to determine the antibacterial properties of pomegranate peel extract in vivo. In particular, they focused on the punicalin, punicalagin and ellagic acid present in the peel extract. The researchers infected C3H/He mice with the bacterial pathogen Citrobacter rodentium, a bacterium that mimics the enteropathogenic bacterium, Escherichia coli. Prior to infection, the mice were orally treated with water or pomegranate peel extract. Twelve days after infection, the researchers examined C. rodentium colonization of the colon and spleen, as well as changes in tissue and gene expression. Fecal excretions were also analyzed for C. rodentium. The results revealed that the pomegranate peel extract reduced weight loss and mortality induced by C. rodentium infection. The extract also reduced C. rodentium colonization of the spleen. Additionally, pomegranate peel extract decreased the extent of damage in the colon caused by C. rodentium infection. In sum, pomegranate fruit peel extract contains bioactive compounds that can help reduce the severity of C. rodentium infection in vivo.   Vitamin D may protect against young-onset colorectal cancer Dana-Farber Cancer Institute and Harvard  School of Public Health, September 1, 2021 Consuming higher amounts of Vitamin D - mainly from dietary sources - may help protect against developing young-onset colorectal cancer or precancerous colon polyps, according to the first study to show such an association. The study, recently published online in the journal Gastroenterology, by scientists from Dana-Farber Cancer Institute, the Harvard T.H. Chan School of Public Health, and other institutions, could potentially lead to recommendations for higher vitamin D intake as an inexpensive complement to screening tests as a colorectal cancer prevention strategy for adults younger than age 50. While the overall incidence of colorectal cancer has been declining, cases have been increasing in younger adults - a worrisome trend that has yet to be explained. The authors of the study, including senior co-authors Kimmie Ng, MD, MPH, of Dana-Farber, and Edward Giovannucci, MD, DSc., of the T.H. Chan School, noted that vitamin D intake from food sources such as fish, mushrooms, eggs, and milk has decreased in the past several decades. There is growing evidence of an association between vitamin D and risk of colorectal cancer mortality. However, prior to the current study, no research has examined whether total vitamin D intake is associated with the risk of young-onset colorectal cancer. “Vitamin D has known activity against colorectal cancer in laboratory studies. Because vitamin D deficiency has been steadily increasing over the past few years, we wondered whether this could be contributing to the rising rates of colorectal cancer in young individuals,” said Ng, director of the Young-Onset Colorectal Cancer Center at Dana-Farber. “We found that total vitamin D intake of 300 IU per day or more - roughly equivalent to three 8-oz. glasses of milk - was associated with an approximately 50% lower risk of developing young-onset colorectal cancer.” The results of the study were obtained by calculating the total vitamin D intake - both from dietary sources and supplements - of 94,205 women participating in the Nurses' Health Study II (NHS II). This study is a prospective cohort study of nurses aged 25 to 42 years that began in 1989. The women are followed every two years by questionnaires on demographics, diet and lifestyle factors, and medical and other health-related information. The researchers focused on a primary endpoint - young-onset colorectal cancer, diagnosed before 50 years of age. They also asked on a follow-up questionnaire whether they had had a colonoscopy or sigmoidoscopy where colorectal polyps (which may be precursors to colorectal cancer) were found. During the period from 1991 to 2015 the researchers documented 111 cases of young-onset colorectal cancer and 3,317 colorectal polyps. Analysis showed that higher total vitamin D intake was associated with a significantly reduced risk of early-onset colorectal cancer. The same link was found between higher vitamin D intake and risk of colon polyps detected before age 50. The association was stronger for dietary vitamin D - principally from dairy products - than from vitamin D supplements. The study authors said that finding could be due to chance or to unknown factors that are not yet understood. Interestingly, the researchers didn't find a significant association between total vitamin D intake and risk of colorectal cancer diagnosed after age 50. The findings were not able to explain this inconsistency, and the scientists said further research in a larger sample is necessary to determine if the protective effect of vitamin D is actually stronger in young-onset colorectal cancer. In any case, the investigators concluded that higher total vitamin D intake is associated with decreased risks of young-onset colorectal cancer and precursors (polyps). “Our results further support that vitamin D may be important in younger adults for health and possibly colorectal cancer prevention,” said Ng. “It is critical to understand the risk factors that are associated with young-onset colorectal cancer so that we can make informed recommendations about diet and lifestyle, as well as identify high risk individuals to target for earlier screening.”     Choosing personal exercise goals, then tackling them immediately is key to sustaining change University of Pennsylvania, September 1, 2021 When people set their own exercise goals – and then pursue them immediately – it's more likely to result in lasting positive changes, according to a new study at the Perelman School of Medicine at the University of Pennsylvania. The results of this research are especially important because they were found among an underserved population that is at particularly high risk of having or developing heart conditions. The study was published in JAMA Cardiology. “Most behavior change programs involve goal-setting, but the best way to design that process is unknown,” said lead author Mitesh Patel, MD, MBA, an associate professor of Medicine at Penn and vice president for Clinical Transformation at Ascension. “Our clinical trial demonstrated that physical activity increased the most when patients chose their goals rather than being assigned them, and when the goals started immediately rather than starting lower and gradually increasing over time. These findings are particularly important because the patients were from lower-income neighborhoods and may face a number of challenges in achieving health goals.” This study consisted of 500 patients from low-income neighborhoods, mainly in West Philadelphia but also elsewhere in and outside of the city. Participants either had a cardiovascular disease or were assessed to have a near-10 percent risk of developing one within a decade. These high-risk patients stood to greatly gain from increased physical activity. Patel's previous work at the Penn Medicine Nudge Unit often focused on the use of gamification, a concept used to create behavioral change by turning it into a game. The work usually tested whether playing a game attached to physical activity goals could make significant increases against not playing a game, or between different versions of a game. As with past studies, every participant was given a wearable step tracker that recorded their daily step counts through Penn's Way to Health platform. But what set this study apart from many of its predecessors was that the main outcomes of the research were less about participation in the games themselves and more about how goals were established, as well as when participants were encouraged to pursue them. Once every participant got their wearable step counter, they were given a week or two to get used to it. This time period also functioned as a baseline-setting period for everyone's pre-intervention daily step count. After that, participants were randomly assigned to the control group, which didn't have step goals or games attached, or one of the gaming groups with goals. Those in the gamified group also went through two other sets of random assignments. One determined whether they'd have input on their step goal, or whether they'd just be assigned a standard one. The second decided whether each participant would immediately start working toward their goals (for the entire 16-week intervention), or whether they'd ramp up to it, with minor increases in goals, until the full goals kicked in at week nine. After analyzing the results, the researchers saw that the only group of participants who achieved significant increases in activity were those who chose their own goals and started immediately. They had the highest average increase in their steps compared to the group with no goals, roughly 1,384 steps per day. And, in addition to raw step counts, the study also measured periods of sustained, high activity, amounting to an average increase of 4.1 minutes daily. Comparatively, those who were assigned their goals or had full goals delayed for half the intervention only increased their daily steps above the control group's average by between 500 and 600 steps. “Individuals who select their own goals are more likely to be intrinsically motivated to follow through on them,” said Kevin Volpp, MD, PhD, director of the Center for Health Incentives and Behavioral Economics. “They feel like the goal is theirs and this likely enables greater engagement.” The study didn't end when the researchers turned the games off. Participants kept their activity trackers, and in the eight weeks following the intervention, the group that chose their goals and started immediately kept up their progress. In fact, they achieved almost the exact same average in steps – just three less than during the active games. “It is exciting to see that the group that increased their activity levels by the most steps maintained those levels during follow-up,” Patel said. “This indicates that gamification with self-chosen and immediate goals helped these patients form a new habit.” Many programs, whether offered through work or by health insurance companies, offer incentives for boosts in physical activity. But these goals are often fairly static and assigned based on round numbers. Patel, Volpp, and colleagues believe this research suggests that adjusting goal setting in these programs can have a significant impact. And if these adjustments lead to gains among people with lower incomes, whom cardiovascular disease kill at 76 percent higher rates, that could be particularly important.           “Goal-setting is a fundamental element of almost every physical activity program, whether through a smartphone app or in a workplace wellness program,” Volpp said. “Our findings reveal a simple approach that could be used to improve the impact of these programs and the health of their patients.”   Comparing seniors who relocate long-distance shows that where you live affects your longevity Massachusetts Institute of Technology, September 1, 2021 Would you like to live longer? It turns out that where you live, not just how you live, can make a big difference. That's the finding of an innovative study co-authored by an MIT economist, which examines senior citizens across the U.S. and concludes that some locations enhance longevity more than others, potentially for multiple reasons. The results show that when a 65-year-old moves from a metro area in the 10th percentile, in terms of how much those areas enhance longevity, to a metro area the 90th percentile, it increases that person's life expectancy by 1.1 years. That is a notable boost, given that mean life expectancy for 65-year-olds in the U.S. is 83.3 years. "There's a substantively important causal effect of where you live as an elderly adult on mortality and life expectancy across the United States," says Amy Finkelstein, a professor in MIT's Department of Economics and co-author of a newly published paper detailing the findings. Researchers have long observed significant regional variation in life expectancy in the U.S., and often attributed it to "health capital"—tendencies toward obesity, smoking, and related behavioral factors in the regional populations. But by analyzing the impact of moving, the current study can isolate and quantify the effect that the location itself has on residents. As such, the research delivers important new information about large-scale drivers of U.S. health outcomes—and raises the question of what it is about different places that affects the elderly's life expectancy. One clear possibility is the nature of available medical care. Other possible drivers of longevity include climate, pollution, crime, traffic safety, and more. "We wanted to separate out the role of people's prior experiences and behaviors—or health capital—from the role of place or environment," Finkelstein says. The paper, "Place-Based Drivers of Mortality: Evidence of Migration," is published in the August issue of the American Economic Review. The co-authors are Finkelstein, the John and Jennie S. MacDonald Professor of Economics at MIT, and Matthew Gentzkow and Heidi Williams, who are both professors of economics at Stanford University. To conduct the study, Finkelstein, Gentzkow, and Williams analyzed Medicare records from 1999 to 2014, focusing on U.S. residents between the ages of 65 and 99. Ultimately the research team studied 6.3 million Medicare beneficiaries. About 2 million of those moved from one U.S. "commuting zone" to another, and the rest were a random 10 percent sample of people who had not moved over the 15-year study period. (The U.S. Census Bureau defines about 700 commuting zones nationally.) A central element of the study involves seeing how different people who were originally from the same locations fared when moving to different destinations. In effect, says Finkelstein, "The idea is to take two elderly people from a given origin, say, Boston. One moves to low-mortality Minneapolis, one moves to high-mortality Houston. We then compare thow long each lives after they move." Different people have different health profiles before they move, of course. But Medicare records include detailed claims data, so the researchers applied records of 27 different illnesses and conditions—ranging from lung cancer and diabetes to depression—to a standard mortality risk model, to categorize the overall health of seniors when they move. Using these "very, very rich pre-move measures of their health," Finkelstein notes, the researchers tried to account for pre-existing health levels of seniors from the same location who moved to different places. Still, even assessing people by 27 measures does not completely describe their health, so Finkelstein, Gentzkow, and Williams also estimated what fraction of people's health conditions they had not observed—essentially by calibrating the observed health of seniors against health capital levels in places they were moving from. They then consider how observed health varies across individuals from the same location moving to different destinations and, assuming that differences in unobserved health—such as physical mobility—vary in the same way as observed differences in health, they adjust their estimates accordingly. All told, the study found that many urban areas on the East and West Coasts—including New York City, San Francisco, and Miami—have positive effects on longevity for seniors moving there. Some Midwestern metro areas, including Chicago, also score well. By contrast, a large swath of the deep South has negative effects on longevity for seniors moving there, including much of Alabama, Arkansas, Louisiana, and northern Florida. Much of the Southwest, including parts of Texas, Oklahoma, New Mexico, and Arizona, fares similarly poorly. The scholars also estimate that health capital accounts for about 70 percent of the difference in longevity across areas of the U.S., and that location effects account for about 15 percent of the variation. "Yes, health capital is important, but yes, place effects also matter," Finkelstein says. Other leading experts in health economics say they are impressed by the study. Jonathan Skinner, the James O. Freeman Presidential Professor of Economics, Emeritus, at Dartmouth College, says the scholars "have provided a critical insight" into the question of place effects "by considering older people who move from one place to another, thus allowing the researchers to cleanly identify the pure effect of the new location on individual health—an effect that is often different from the health of long-term residents. This is an important study that will surely be cited and will influence health policy in coming years." The Charlotte Effect: What makes a difference? Indeed, the significance of place effects on life expectancy is also evident in another pattern the study found. Some locations—such as Charlotte, North Carolina—have a positive effect on longevity but still have low overall life expectancy, while other places—such as Santa Fe New Mexico—have high overall life expectancy, but a below-average effect on the longevity of seniors who move there. Again, the life expectancy of an area's population is not the same thing as that location's effect on longevity. In places where, say, smoking is highly prevalent, population-wide longevity might be subpar, but other factors might make it a place where people of average health will live longer. The question is why. "Our [hard] evidence is about the role of place," Finkelstein says, while noting that the next logical step in this vein of research is to look for the specific factors at work. "We know something about Charlotte, North Carolina, makes a difference, but we don't yet know what." With that in mind, Finkelstein, Gentzkow, and Williams, along with other colleagues, are working on a pair of new studies about health care practices to see what impact place-based differences may have; one study focuses on doctors, and the other looks at the prescription opioid epidemic. In the background of this research is a high-profile academic and policy discussion about the impact of health care utilization. One perspective, associated with the Dartmouth Atlas of Health Care project, suggests that the large regional differences in health care use it has documented have little impact on mortality. But the current study, by quantifying the variable impact of place, suggest there may be, in turn, a bigger differential impact in health care utilization yet to be identified. For her part, Finkelstein says she would welcome further studies digging into health care use or any other factor that might explain why different places have different effects on life expectancy; the key is uncovering more hard evidence, wherever it leads. "Differences in health care across places are large and potentially important," Finkelstein says. "But there are also differences in pollution, weather, [and] other aspects. … What we need to do now is get inside the black box of 'the place' and figure out what it is about them that matters for longevity."   Gut bacteria influence brain development Researchers discover biomarkers that indicate early brain injury in extreme premature infants University of Vienna (Austria), September 3, 2021 The early development of the gut, the brain and the immune system are closely interrelated. Researchers refer to this as the gut-immune-brain axis. Bacteria in the gut cooperate with the immune system, which in turn monitors gut microbes and develops appropriate responses to them. In addition, the gut is in contact with the brain via the vagus nerve as well as via the immune system. "We investigated the role this axis plays in the brain development of extreme preterm infants," says the first author of the study, David Seki. "The microorganisms of the gut microbiome - which is a vital collection of hundreds of species of bacteria, fungi, viruses and other microbes - are in equilibrium in healthy people. However, especially in premature babies, whose immune system and microbiome have not been able to develop fully, shifts are quite likely to occur. These shifts may result in negative effects on the brain," explains the microbiologist and immunologist. Patterns in the microbiome provide clues to brain damage "In fact, we have been able to identify certain patterns in the microbiome and immune response that are clearly linked to the progression and severity of brain injury," adds David Berry, microbiologist and head of the research group at the Centre for Microbiology and Environmental Systems Science (CMESS) at the University of Vienna as well as Operational Director of the Joint Microbiome Facility of the Medical University of Vienna and University of Vienna. "Crucially, such patterns often show up prior to changes in the brain. This suggests a critical time window during which brain damage of extremely premature infants may be prevented from worsening or even avoided." Comprehensive study of the development of extremely premature infants Starting points for the development of appropriate therapies are provided by the biomarkers that the interdisciplinary team was able to identify. "Our data show that excessive growth of the bacterium Klebsiella and the associated elevated γδ-T-cell levels can apparently exacerbate brain damage," explains Lukas Wisgrill, Neonatologist from the Division of Neonatology, Pediatric Intensive Care Medicine and Neuropediatrics at the Department of Pediatric and Adolescent Medicine at the Medical University of Vienna. "We were able to track down these patterns because, for a very specific group of newborns, for the first time we explored in detail how the gut microbiome, the immune system and the brain develop and how they interact in this process," he adds. The study monitored a total of 60 premature infants, born before 28 weeks gestation and weighing less than 1 kilogram, for several weeks or even months. Using state-of-the-art methods - the team examined the microbiome using 16S rRNA gene sequencing, among other methods - the researchers analysed blood and stool samples, brain wave recordings (e.g. aEEG) and MRI images of the infants' brains. Research continues with two studies The study, which is an inter-university clusterproject under the joint leadership by Angelika Berger (Medical University of Vienna) and David Berry (University of Vienna), is the starting point for a research project that will investigate the microbiome and its significance for the neurological development of prematurely born children even more thoroughly. In addition, the researchers will continue to follow the children of the initial study. "How the children's motoric and cognitive skills develop only becomes apparent over several years," explains Angelika Berger. "We aim to understand how this very early development of the gut-immune-brain axis plays out in the long term. " The most important cooperation partners for the project are already on board: "The children's parents have supported us in the study with great interest and openness," says David Seki. "Ultimately, this is the only reason we were able to gain these important insights. We are very grateful for that."     Amino acid supplements may boost vascular endothelial function in older adults: Study University of Alabama, August 28, 2021 A combination of HMB (a metabolite of leucine), glutamine and arginine may improve vascular function and blood flow in older people, says a new study. Scientists from the University of Alabama report that a supplement containing HMB (beta-hydroxy-beta-methylbutyrate), glutamine and arginine (Juven by Abbott Nutrition) increased flow-mediated dilation (FMD - a measure of blood flow and vascular health) by 27%, whereas no changes were observed in the placebo group. However, the researchers did not observe any changes to markers of inflammation, including high-sensitivity C-reactive protein (hsCRP) and tumor necrosis factor-alpha (TNF-alpha) “Our results indicate that 6 months of dietary supplementation with HMB, glutamine and arginine had a positive impact on vascular endothelial function in older adults,” wrote the researchers, led by Dr Amy Ellis in the European Journal of Clinical Nutrition . “These results are clinically relevant because reduced endothelial-dependent vasodilation is a known risk factor for cardiovascular diseases. “Further investigation is warranted to elucidate mechanisms and confirm benefits of foods rich in these amino acids on cardiovascular outcomes.” The study supported financially by the National Center for Complementary and Alternative Medicine. Study details Dr Ellis and her co-workers recrtuited 31 community-dwelling men and women aged between 65 and 87 to participate in their randomized, placebo-controlled trial. The participants were randomly assigned to one of two groups: The first group received the active supplements providing 3 g HMB, 14 g glutamine and 14 g arginine per day; while the second group received a placebo. After six months of intervention, the researchers found that FMD increased in the HMB + glutamine + arginine group, but no such increases were observed in the placebo group. While no changes in CRP or TNF-alpha levels were observed in the active supplement group, a trend towards an increase in CRP levels was observed in the placebo group, but this did not reach statistical significance, they noted. “Although no previous studies have examined this combination of amino acids on vascular function, we hypothesized that the active ingredients of the supplement would act synergistically to improve endothelial function by reducing oxidative stress and inflammation,” wrote the researchers. “However, although we observed a trend for increasing hsCRP among the placebo group (P=0.059), no significant changes in hsCRP or TNF-alpha were observed for either group. “Possibly, the effects of the supplement on reducing oxidative stress and inflammation were subclinical, or the high variability in these biomarkers, particularly hsCRP, among our small sample could have precluded visible differences.” The researchers also noted that an alternate mechanism may also be responsible, adding that arginine is a precursor of the potent vasodilator nitric oxide “Although investigation of this mechanism was beyond the scope of this study, it is feasible that the arginine in the supplement improved endothelial-dependent vasodilation by providing additional substrate for nitric oxide synthesis,” they added.     Moderate coffee drinking associated with lower risk of mortality during 11-year median follow-up Semmelweis University (Bulgaria), September 1 2021.  Research presented at ESC (European Society of Cardiology) Congress 2021 revealed a lower risk of dying from any cause during an 11-year median period among light to moderate coffee drinkers in comparison with men and women who had no intake. The study included 468,629 UK Biobank participants of an average age of 56.2 years who had no indications of heart disease upon enrollment. Coffee intake was classified as none, light to moderate at 0.5 to 3 cups per day or high at over 3 cups per day. A subgroup of participants underwent magnetic resonance imaging (MRI) of the heart to assess cardiac structure and function.  Light to moderate coffee intake during the follow-up period was associated with a 12% decrease in the risk of dying from any cause, a 17% lower risk of cardiovascular mortality and a 21% reduction in the incidence of stroke in comparison with the risks associated with not drinking coffee.  “The imaging analysis indicated that, compared with participants who did not drink coffee regularly, daily consumers had healthier sized and better functioning hearts,” reported study author Judit Simon, of Semmelweis University in Budapest. “This was consistent with reversing the detrimental effects of aging on the heart.” “To our knowledge, this is the largest study to systematically assess the cardiovascular effects of regular coffee consumption in a population without diagnosed heart disease,” she announced. “Our results suggest that regular coffee consumption is safe, as even high daily intake was not associated with adverse cardiovascular outcomes and all-cause mortality after a follow-up of 10 to 15 years. Moreover, 0.5 to 3 cups of coffee per day was independently associated with lower risks of stroke, death from cardiovascular disease, and death from any cause.”

Has self-doubt ever caused you to procrastinate when trying to achieve your dream? In this episode, Internal Medicine Resident Dr. Ariela Baur shares her inspiring story of ambition, resilience and discipline as she silenced her self-doubt in order to attain success. German-born Dr. Baur attended medical school at Semmelweis University in Budapest, Hungary & Hamburg, Germany. After graduating in 2016, she worked for 3 years in cardiology in Germany, before she decided to take the leap and pursue residency in the United States. Though she knew she could have served as a doctor in Germany, she realized that it was not what she wanted for herself, and that she had to make a change. She knew that the transition would not be easy, but she was willing to do whatever it took to reach her goal. One of the most outstanding points to note about Dr. Baur's journey is that she passed USMLE Steps 1, 2 and 3 all within 2 years. When she was asked how she was able to carry this out, she highlighted the following: She engaged in a six week Kaplan course which helped her to prepare for Step 1 USMLE, especially with regard to adjusting to the American exam style. She found a group of supportive colleagues with whom she could study and share experiences. She was disciplined and driven and used her time wisely when preparing for the exam. Though it was difficult, despite the rescheduling of the USMLE exams due to COVID, and other challenges, she persisted. After having taken the exams, Dr. Baur outlined the following about her application cycle: When the results came in, her step 1 score was 211, and though this disappointed her, she changed her strategy and went full force into preparing for steps 2 and 3, which she crushed! To improve her Step 2 scores, she focused more on practice questions, which yielded success. During the gaps between exams, Dr. Baur did rotations with the private practice of various physicians in order to build her US clinical experience and enhance her application. Though she applied to over 100 programs in Internal Medicine and Emergency Medicine, she only landed 2 interviews. She also did not let that discourage her, and decided to let her personality and dedication shine through during the interviews. After all, you only need one successful interview! Dr. Baur hopes to inspire IMGs to: Study hard, but take breaks as needed. Do not allow vigorous and constant studying to compromise your mental health. Follow a strict schedule but reward yourself accordingly. The sacrifice is worth it! You can reach out to Dr. Baur to find out more about her story and to seek advice via her instagram @arielii_b Listen to the full episode using the links below: Apple: https://podcasts.apple.com/us/podcast/70-imgroadmap-series-78-dr-ariela-baur-internal-medicine/id1490731292?i=1000523480099 Spotify: https://open.spotify.com/episode/6wDrhmPwpa0TdgvvIfex2M Google Podcasts: https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy9mOGMzY2EwL3BvZGNhc3QvcnNz/episode/Njk3YzMwMWEtNzE2NS00ZWFiLTgxMmQtNzBjMWNkMDM1ODZj?sa=X&ved=0CAUQkfYCahcKEwjAjPnIhPrwAhUAAAAAHQAAAAAQAQ --- Support this podcast: https://anchor.fm/ninalum/support

Dr. Alexandros Grous graduate from the School of Dentistry, University of Athens (1980).He completed a certificate, Post Graduate Prosthodontics Specialty Program at Tufts University School of Dental Medicine, Boston (1981-1983).  He became an assistant clinical professor of Prosthodontics, Restorative Dept. TUFTS University (1983-1984). He obtained his PhD, diploma at the School of Dentistry, University of Athens (2003).He is a part time clinical instructor at the postgraduate Prosthodontics department, School of Dentistry, University of Athens, teaching macro photography courses to postgraduate dental students at the of School of Dentistry, University of Athens.He maintains a full time private practice limited to Prosthodontics , Esthetics and Implant Dentistry, in Athens. He is an active member of the European Academy of Esthetic Dentistry (EAED-1996), Fellow of the International Team of Implantology (ITI ), Member of the International College of Prosthodontics, the European Association of Osseointegration, the European Prosthodontic Association, Active member and Past President (2007-2009) of the Hellenic Society of Odontostomatological Research and past President of Tufts Prosthodontics Alumni Charitable Organization (2011-2016).Active lecturer nationally and internationally in conventions and continuing education courses on various Prosthodontic, Esthetic and Implant  Dentistry topics. Dr. Stefania A. Grous received on 2011, her DMD degree from the English program of Semmelweis University, School of Dental Medicine, Budapest, Hungary.On 2013 she graduated from the two-year postgraduate program of Advanced Education in Aesthetic Dentistry, Tufts University School of Dental Medicine, Boston, USA.  On 2015 she obtained her MSc degree of Conservative Dentistry, from the University College of London (UCL), London, UK. The study of her project was on the subject of 3D printing and the relevant updated technologies. Currently she practices at the Grous Dental Clinic, limited to Esthetic and Restorative Dentistry, Prosthodontics and Implant Dentistry.https://www.grousdentalclinic.comhttps://www.linkedin.com/in/stefania-grous-40791a44/https://www.linkedin.com/in/alex-grous-athens-greece-b2899511/https://www.instagram.com/stefgrous/--------------------------www.theinternationaldentist.comLinkedIn: www.linkedin.com/in/drgabrielalagrecaFB & IG @theinternationaldentist 

In this episode of Instagram Live recording, I invited Dr. Daniel Vegh, a young faculty member and prosthodontist from Semmelweis University to share with us his journey of learning about 3D printing for dentistry, his recent accomplishments in the space, and his vision for its future.  Dr. Vegh is the author behind @3d_printing_dentistry on Instagram. Daniel also shared how he leveraged social media to build a community for dental 3D printing both locally and internationally.  He also brought us a few examples of his past works on camera. Additional highlights of this interview: What is the current status of establishing a formal curriculum in dental schools?Who is most interested in adopting 3D printing in their dental practices? How to find other dentists who are actively using 3D printing? What are some suggestions for new dentists to space? Full interview recording including video recording and additional links can be found here: https://3dheals.com/learning-dental-3d-printing-through-social-media-an-interview-with-dr-daniel-vegh Who is Dr. Daniel Vegh? Dr. Dániel Végh DMD, Ph.D.Specialist in Conservative Dentistry and ProsthodonticsSemmelweis University - Department of Prosthodontics - Budapest, HungaryIn his own words, " My name is Dr. Daniel Vegh! I earned my DMD degree at the Semmelweis University in 2015!I am working at the Department of Prosthodontics since then! I am a prosthodontist since 2018, and I earned my Ph.D. Degree in 2019, the topic was diabetes and oral complications!As a regular participant of dental congresses, I meet with 3D printing technology on-site, and I become a fanatic! I found out that a lot of my colleagues are interested in it, but there is a lack of experience and knowledge about it! I started my Instagram page ( @3d_printing_dentistry), where my aim is to build International connections! Semmelweis University established SE3D lab, an innovative place dedicated to 3D printing for students and staff! It has research, educational and clinical aspects!"Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)

What do tumor cells use for food? Researcher Christos Chinopoulos discusses a brand new technology called Reverse Phase Protein Array (RPPA) that quantifies protein expressions and determines what pathways are important for cancer metabolism.  By viewing cancer as a metabolic disease, it may provide tools to inhibit those pathways. This conversation covers A general oncometabolites review regarding tumor heterogeneity and comparisons to healthy tissue, Specific focuses of Chinopoulos' study, including breast, brain, and kidney cancers, and The timeline of the study and the role of glutamine, glucose, and glycolysis in cancer cells. Christos Chinopoulos is an associate professor with Semmelweis University and the project manager of their RPPA facility. He gives listeners a glimpse of this exciting technique, likening it to “western blotting on steroids.” Thus far they have been able to semi quantify the expression of several hundreds of proteins from thousands of samples. These samples include solid tumor tissue and healthy tissue as a control. Several proteins on a pathway can be examined at the same time. This gives researchers an idea if that particular pathway is important in cancer metabolism. This precise technology is along the lines of searches for new cancer treatments like a mitochondria cancer cure and caloric restriction and cancer, but at the pathway level. Chinopoulos believes that by investigating these metabolic pathways, which are a small part of the glutamine metabolism pathway, they can identify what is critical for tumor survival. They aim to quantify the expression of proteins participating in that particular pathway of glutamine metabolism, which could lead to ways to inhibit those pathways and starve the cancer cells. He hopes to present concrete data over the next year. For more, see rppa.hu. Available on Apple Podcasts: apple.co/2Os0myK

Professor György Nagy from the Semmelweis University, Hungry. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Professor György Nagy discusses his latest paper on EULAR definition of difficult-to-treat RA

We need to talk about legal education. As the last couple of episodes of our podcast have demonstrated, preserving the rule of law depends to a large quantity on people working in legal professions. What prosecutors, judges, attorneys, and, to a large degree, people working in the executive branch have in common, is a law degree. This means that we have to turn to legal education itself in order to find answers to the question how rule of law systems may remain or become resilient against authoritarian backsliding. Are current legal education systems in the EU equipped for this task? How are they affected by the turn to authoritarianism and illiberalism in a number of member states? And what are intrinsic shortcomings of academic and professional legal education?   This is what LENNART KOKOTT discusses with our distinguished guests: ANNA KATHARINA MANGOLD, a professor of European Law at the Europa-University Flensburg, a member of the Education Committee of the German Women Lawyers' Association, and an Associate Editor of Verfassungsblog covering anti-discrimination and gender issues, GABOR ATTILA TOTH, he writes primarily about the fields of human rights and constitutional theory, with a current focus on the legal attributes of authoritarianism. He teaches law at the University of Debrecen and bioethics at the Semmelweis University in Budapest, ATTRACTA O'REGAN, a solicitor and barrister, Head of Law Society of Ireland Professional Training and rule of law advisor to the Council of Bars and Law Societies of Europe (CCBE), and JAKUB URBANIK, Chair of Roman Law and the Law of the Antiquity at Warsaw University.

Today, is May 5, 2020, and The World Health Organization (WHO) has declared May 5th every year as the “ Save Lives: Clean Your Hands” Day. It is the day that we must give thanks to nurses, midwives, and Dr. Ignaz Semmelweis known as the Father of Hand-Washing and Savior of Mothers, Who? Who is Dr. Semmelweis? Let me tell you a story about Dr. Ignaz Semmelweis and why he is called the Father of HandWashing, and during this time of coronavirus pandemic, where everyone is practicing public health hygiene of handwashing for at least 20 seconds can kill the virus. You will learn that washing hands can actually save lives, literally. However, the moral of the story is that sometimes showing data, numbers, and graphs and charts is not enough, it is the story behind the number that connects with your audience that’s most important. For the clinicians, researchers, data scientists, epidemiologists, biostatisticians, and public health professionals who love to crunch numbers and speak in number, we must always remember that people don’t remember the number, but they remember the story. Let’s our story begin in 1846 in Vienna Austria with a Hungarian doctor, Dr. Ignaz Semmelweis. To learn more medical training and health-related professional careers at Semmelweis University in Budapest, Hungary, visit https://semmelweis.hu/english/ --- Send in a voice message: https://anchor.fm/whatispublichealth/message Support this podcast: https://anchor.fm/whatispublichealth/support

The test of the morality of a society is what it does for its children. - Dietrich Bonhoeffer Dr. Moshe Cohen is a trained physician, a graduate of Semmelweis University in Budapest, Hungary. He worked as a doctor in the Cardiology and Internal Medicine departments at Tel Aviv Sourasky Medical Center (Ichilov).  Dr. Cohen is the founder and CEO of M.D. International Studies. He has 4 children.  Dr. Moshe Cohen is the author of two novels, published in Hebrew: "Village of Fools" (2003) and "Sadly Bare" (2000).  In addition, Dr. Moshe Cohen is a guest lecture in the field of Cardiology in Zagreb University Medical School and Humanitas Univeristy in Milan. #DrKeith #TheScalpel #News #Politics #Future #Conservatives #Democrats #hypocrites #liberals #RobertMueller #immigration #presidentialcandidate #Mueller #sports #brands #america #freedom #branding #progressive #truth #history #SJW #thescalpel #Dependence #independence 

Audible Bleeding is excited to announce our new collaboration with the Journal of Vascular Surgery. We aim to present high impact articles in a digestible audio format and provide insights into their broader context and how the research developed through interviews with the journal editors and highlighted authors. Our guests on this episode are Journal of Vascular Surgery Editors, Dr. Peter Gloviczki and Dr. Peter Lawrence to introduce this collaboration and discuss their session at the upcoming #VAM19. B4: CRITICAL ISSUES FOR AUTHORS AND REVIEWERS A joint session of JVS/EJVES/JAMA Surgery Friday, June 14, 2019 6:30 - 8:00 am Dr. Peter Gloviczki is the Editor-in-Chief of the Journal of Vascular Surgery.  He completed his general surgery and vascular training at Semmelweis University in Budapest, Hungary, at St. Michel and St. Joseph Hospitals in Paris, France, and at the Mayo Clinic in Rochester, MN, where he joined faculty and then became Chair of the Division of Vascular and Endovascular Surgery from 2000-2010.  He is a Past President of the SVS and WFVS, as well as numerous other national and regional vascular societies. He has over 400 peer-reviewed publications, and he has edited seven textbooks, including multiple editions of Rutherford’s Vascular Surgery.  Dr. Peter Lawrence is the Senior Editor of the Journal of Vascular Surgery.  He completed his general surgery and vascular training at Columbia-Presbyterian Medical Center in New York, spent his early career at the University of Utah but now serves as the Chief of Vascular Surgery and the Bergman Chair in Vascular Research at University of California Los Angeles. He is a Past President of the SVS and SVS Foundation.  Dr. Lawrence is committed to medical education as seen by his involvement in the National Board of Medical Examiners and the American Boards of Surgery and Vascular Surgery. He has served on the editorial board or as a selected reviewer for eleven medical journals.  Support Audible Bleeding!

This week's episode is with Katja Bondartschuk, a German medical student at Semmelweis University here in Budapest. Katja's been living in Hungary for several years now, speaks Hungarian well, plays basketball, trains CrossFit, and has a background in singing.

Holistic approach to sports and wellness… Anna Eszter Hajosi, New York State Board Certified Licensed Acupuncturist and founder of Holistic Athlete NYC (providing comprehensive, holistic approach to healing, recovery and wellbeing through the use of acupuncture, nutrition, corrective exercises and other traditional modalities) and avid triathlete, joins guest host Jessica Brodkin [Episode 11] in the MouthMedia Network studio powered by Sennheiser.In this episode: How Eszter Hajosi earned her undergraduate degree in Dietetics and Nutrition from Semmelweis University, the oldest medical school in Hungary, and her Master of Science degree in Acupuncture from Tri-State College of Acupuncture Whether one can heal the body with just positive mind set and needles, etc. and whether we change the structure of brain How Eszter Hajosi felt guided to go to the US and New York, without knowing English, and then decided to go to acupuncture school instead of becoming a doctor Eszter Hajosi’s primary work with athletes and dancers Running triathlons and a half iron man As you get stronger you can get injured often, it takes tome for body to adjust Eszter Hajosi on working with a psychiatrist from Columbia University, who refers patients who aren’t being helped by medication or who want to try another method Using the tongue as a diagnostic tool The quick results possible with acupuncture When Eszter Hajosi had a fibroid Increasing blood flow, meridians How emotions should not dictate what we do, discipline and creating habits Diagnosing posture

Hand hygiene is the number one line of defense when it comes to controlling the spread of healthcare-associated infections (HAI) and infectious disease.  Since we know that antibiotic and antimicrobial resistance is on the rise, and few new antibiotics are being developed, it becomes exceedingly important that we prevent people from acquiring these infections in the first place. Checkout our extensive coverage of the Infection Prevention and Control (IPAC) space We know that hand-washing is effective when done right, and we know that when monitored, we do it right. In fact, right after we recorded this podcast the Jama Network showed us that patient mortality decreased during unannounced accreditation surveys at US Hospitals. The point is that you can expect what you inspect. Episode 004 (part 3 of our IPAC series): On this episode, we get into the details with Tamás Haidegger and discuss: Why hand hygiene is so important How the struggle to get it right goes back to the 1800s The complex human psychology that we need to address to solve this problem The astonishing number of people who fail hand-washing tests even when they know they're being monitored Engineering solutions that can help keep us objective How hand-hygiene can save the U.S. healthcare system $9 Billion next year This conversation is way more fun than you think it's going to be and very informative. I hope you enjoy! - Don Lee   About Tamás Haidegger Tamás Haidegger received his M.Sc. degrees from the Budapest University of Technology and Economics (BME) in Electrical Engineering and Biomedical Engineering in 2006 and 2008, respectively. His Ph.D. thesis (2011) was based on a neurosurgical robot he helped develop when he was a visiting scholar at the Johns Hopkins University. His main field of research is control/teleoperation of surgical robots, image-guided therapy, and supportive medical technologies. Currently, he is an associate professor at the Óbuda University, serving as the deputy director of the Antal Bejczy Center for Intelligent Robotic. Besides, he is a research area manager at the Austrian Center for Medical Innovation and Technology (ACMIT), working on minimally invasive surgical simulation and training, medical robotics and usability/workflow assessment through ontologies. Tamás is the co-founder and CEO of a university spin-off—HandInScan—focusing on objective hand hygiene control in the medical environment. They are working together with Semmelweis University, the University Hospital Geneva and the World Health Organization POPS group. About HandInScan HandInScan Zrt. is a health-tech company focusing on the unmet and critical need of reducing healthcare-associated infections (HAIs) that causes more than 250,000 unnecessary deaths in the developed world and 1.4 million cases a day worldwide. HandInScan was formed in 2012 as a spin-off of the Budapest University of Technology and Economics (BME). As a spinoff project, HandInScan was incubated at Demola from 2013. Original founders were private individuals from the engineering development team, aiming to create a device to objectively control hand hygiene performance of medical staff. The innovation and the technology transfer received numerous international awards. After the initial successful validation with early prototypes of the Hand-in-Scan device, the application domains were significantly extended to target clean manufacturing sites, the food industry and high-end tourism. The founders' core team skill set included biomedical engineering, infection prevention and control, electrical engineering, computer science, finance, marketing and project management. The company exclusively licensed the relevant patent from BME, entitled “Method and apparatus for hand disinfection quality control (HU P1000523)”. HandInScan has a key partnership agreement with its regional development partner, the Austrian Center for Medical Innovation and Technology (ACMIT), and continued working together with researchers at BME. http://www.handinscan.com Twitter: @HandInScan Facebook: https://www.facebook.com/handinscan Tamás also mentioned the World Health Organization's Hand Hygiene day on May 5th, 2017. Learn more here. About the Infection Prevention and Control Series This episode is part of The #HCBiz Show's Infection Prevention and Control (IPAC) series. We'd like to thank our partners InfectionControl.tips and the Center of Excellence for Infection Prevention and Control (COE IPAC) for their support and guidance with the series. About InfectionControl.tips InfectionControl.tips is a Pan-Access journal that extends globally and touches locally. www.IC.tips is: Free to Publish. Free to Access and provides Accessible Scientific Services. About Center of Excellence for Infection Prevention and Control (COE IPAC) Center of Excellence for Infection Prevention and Control (COE IPAC) is a collaborative effort to accelerate and support new solutions that hold the promise of significantly advancing infection prevention and control. On a quarterly basis, the Center of Excellence will evaluate at least 3 international innovations – giving them access to independent testing, publication as well as a US commercialization site. The #HCBiz Show! is produced by Glide Health IT, LLC in partnership with Netspective Media.   Soundtrack credit: Acid Lounge by FoolBoyMedia